SANGLIER JEAN-JACQUES | Novartis Pharma Inc., Research, Department of Core Technology

スポンサーリンク

概要

• SANGLIER JEAN-JACQUESの詳細を見る
• 同名の論文著者
• Novartis Pharma Inc., Research, Department of Core Technologyの論文著者

Novartis Pharma Inc., Research, Department of Core Technology | 論文

• Sanglifehrins A, B, C and D, Novel Cyclophilin-binding Compounds Isolated from Streptomyces sp. A92-308110 II. Structure Elucidation, Stereochemistry and Physico-chemical Properties
• Sanglifehrins A, B, C and D, Novel Cyclophilin-binding Compounds Isolated from Streptomyces sp. A92-308110 I. Taxonomy, Fermentation, Isolation and Biological Activity
• Cymbimicin A and B, Two Novel Cyclophilin-binding Structures Isolated from Actinomycetes
• Argyrins, Immunosuppressive Cyclic Peptides from Myxobacteria II. Structure Elucidation and Stereochemistry
• New Insights Rifamycin B Biosynthesis : Isolation of Proansamycin B and 34a-Deoxy-rifamycin W as Early Macrocyclic Intermediates Indicating Two Separated Biosynthetic Pathways

もっと見る

スポンサーリンク